Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC

Deepinder Pal Singh, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-2171

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Settings

Cancer, Radiation Oncology


Cancer is one of the most challenging medical problems, especially head and neck and lung cancers. I am very well trained, well read and highly experienced. I am also a compassionate and caring physician.

I provide my patients with comprehensive medical care including personalized, curative intent treatment. Since my patients deserve only the best, they can be confident knowing they will receive excellent medical care from me. My areas of expertise include stereotactic body radiation therapy and brachytherapy for lung cancers, as well as treating nasopharyngeal, oropharyngeal, oral cavity, laryngeal and hypopharyngeal cancers.

Conditions I Treat:

- Lung cancer
- Head and neck cancers



  • Radiation Oncology - American Board of Radiology


MBBS | Indira Ghandi Medical College

MD | University of Rochester Medical Center

Post-doctoral Training & Residency

07/01/2005 - 06/30/2009
Residency in Radiation Oncology at University of Rochester Medical Center

07/01/2003 - 06/30/2005
Fellowship in Radiation Oncology at University of Rochester Medical Center

09/17/1986 - 12/16/1989
Fellowship in at Postgraduate Institute of Medical Education & Research

08/11/1984 - 06/30/1986
Residency in at Postgraduate Institute of Medical Education & Research

05/23/1982 - 05/22/1983
Residency in at Indira Ghandi Medical College

05/08/1981 - 05/07/1982
Internship in Rotating at Indira Ghandi Medical College

VIEW ALL expand_more


2012 - 2013
Educator of the Year
Sponsor: Association of Residents in Radiation Oncology
Location: University of Rochester

Clinical Trials

Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early- Stage Non-Small-Cell Lung Cancer: A Prospective Randomized Phase II Study

Lead Researcher: Deepinder Pal Singh

This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatment, they will follow up with their radiation oncologist.

View Study Details


Journal Articles

Singh D; Chen Y; Cummings MA; Milano MT. "Inoperable pulmonary carcinoid tumors: local control rates with stereotactic body radiotherapy." Clin Lung Cancer. 2019; in press.

Aujla KS; Katz AW; Singh DP; Okunieff P; Milano MT. "Hypofractionated stereotactic radiotherapy for non-breast or prostate cancer oligometastases: a tale of survival beyond 10 years" . Front Oncol. 2019; in press.

Budnik J; DeNunzio NJ; Singh DP; Milano MT. "Second primary non-small-cell lung cancer after head and neck cancer: a population-based study of clinical and pathologic characteristics and survival outcomes in 3,597 patients" . Clin Lung Cancer. 2019; in press.

Books & Chapters

Chapter Title: Translational Research in Lung Cancer
Book Title: Advances in Radiation Oncology in Lung Cancer
Author List: Singh D; Bylund K; Chen Y
Edited By: Jeremic B
Published By: Springer-Verlag GmbH 2011 in Heidelberg

Chapter Title: Carcinoma of the nasopharynx
Book Title: Textbook of Radiation Oncology: Principles and Practice
Author List: Sharma SC, Singh DP, Jalali R
Published By: Churchill Livingstone 2000